Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Cure51
France
- Paris
- 20/03/2024
- Seed
- $16,260,975
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
- Industry Biotechnology Research
- Website https://www.cure51.com/
- LinkedIn https://www.linkedin.com/company/cure51/
Related People
Nicolas WolikowFounder
France -
Greater Paris Metropolitan Region
Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-up and multinational firms.
Forward-thinking executive with a strong ability to lead and motivate worldwide teams comprising of more than 400 employees.
Managing P&L for business divisions exceeding $200M revenue.
Have been Chief Executive Officer, responsible for strategy implementation, business development and acquisitions initiatives. Currently Chief Digital Officer to transform a large organisation. Passionate about product innovations that shape new customer experiences.
Gravity | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)